IAC HOME
|
DISEASES & VACCINES
Anthrax
FDA Approves Important Anthrax Vaccine Changes
Route changed from SC to IM and initial series doses reduced from 6 to 5
Immunization Materials for Patients & Staff
Vaccine Information Statements
VISs explain both the benefits and risks of a vaccine
More Anthrax Resources
Vaccine-related resources from other organizations
GLT
GRT
 
Photos & Videos
Photos
Access anthrax-related images
 
GLB
GRB
GLT
GRT
 
MORE DISEASES & VACCINES
Anthrax
Hepatitis B
Influenza
Pertussis
Rabies
Smallpox
Chickenpox HPV Measles PCV7 Rotavirus Tetanus
Diphtheria Hib Meningo. PPSV Rubella
Hepatitis A H1N1 Mumps Polio Shingles
 
GLB
GRB
News & Information
Vaccines in the News
Up-to-date media coverage about anthrax
New Releases
Vaccine licensures, resources, and recommendations
What's New at IAC
Chronological listing of new and revised IAC materials
Related Topics
Vaccine Concerns
Articles & Reports
Anthrax Journal Articles
IAC's selection of practical, clinical, and programmatic articles
Vaccine Policy & Licensure
ACIP Recommendations
CDC's Advisory Committee on Immunization Practices
Package Inserts
Manufacturers' labeling of vaccines licensed for use in the United States
FDA Product Approval
Licensure information from the Food and Drug Administration
IOM Publications
Immunization-related reports from the Institute of Medicine
GLT
GRT
 
More From IAC
Subscribe to IAC
Periodicals and email news service - all free!
Support IAC
Your support can make a difference!
Shop IAC
DVDs, schedules, record cards, and more!
 
GLB
GRB
Home spacer Contact Us spacer About Us spacer Support IAC spacer Cite IAC spacer Disclaimer spacer Privacy Policy
Immunization Action Coalition  •  1573 Selby Avenue  •  Saint Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
email admin@immunize.org